Literature DB >> 19581493

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.

Sarah Rosner Preis1, Michael J Pencina, Shih-Jen Hwang, Ralph B D'Agostino, Peter J Savage, Daniel Levy, Caroline S Fox.   

Abstract

BACKGROUND: Individuals with diabetes mellitus are at 2- to 3-fold increased risk for cardiovascular disease (CVD) relative to those without diabetes. Our objective was to examine CVD risk factor level changes among individuals with and without type 2 diabetes mellitus from 1970 to 2005 in the Framingham Heart Study. METHODS AND
RESULTS: We included 4195 participants (3990 with no diabetes and 205 with diabetes) 50 years of age and 3495 participants (3178 with no diabetes and 317 with diabetes) 60 years of age. Contemporaneous CVD risk factor levels were measured; linear regression models were used to assess the interaction between diabetes status and calendar year on CVD risk factor levels. Among 50-year-olds without diabetes mellitus, there was an increase in body mass index of 0.39 kg/m(2) per 10 years, whereas for those with diabetes, there was an increase of 2.52 kg/m(2) (P value for the diabetes-by-calendar year interaction [P for interaction] <0.001). For low-density lipoprotein cholesterol, the mean decrease was -7.43 mg/dL per decade (nondiabetes) and -15.5 mg/dL for diabetes (P for interaction=0.002). For systolic blood pressure, the mean decrease was -3.35 mm Hg per decade (nondiabetes) and -3.50 mm Hg for diabetes (P for interaction=0.97). The direction of the trends for those with diabetes relative to those without diabetes was similar for 60-year-olds.
CONCLUSIONS: Compared with individuals without diabetes mellitus, individuals with diabetes experienced a greater increase in body mass index, a greater decrease in low-density lipoprotein cholesterol, and a similar magnitude of decline in systolic blood pressure. Individuals with diabetes mellitus have not experienced the necessary declines in CVD risk factors to overcome their increased risk of CVD. Further efforts are needed to aggressively control CVD risk factors among individuals with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581493      PMCID: PMC2789428          DOI: 10.1161/CIRCULATIONAHA.108.846519

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

1.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 3.  Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.

Authors:  Sandeep Vijan; Rodney A Hayward
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

4.  A diabetes report card for the United States: quality of care in the 1990s.

Authors:  Jinan B Saaddine; Michael M Engelgau; Gloria L Beckles; Edward W Gregg; Theodore J Thompson; K M Venkat Narayan
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

7.  Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Authors:  Jay S Skyler; Richard Bergenstal; Robert O Bonow; John Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Journal:  Circulation       Date:  2008-12-17       Impact factor: 29.690

8.  Trends in hypercholesterolemia, treatment and control among United States adults.

Authors:  Earl S Ford; Chaoyang Li; William S Pearson; Guixiang Zhao; Ali H Mokdad
Journal:  Int J Cardiol       Date:  2008-12-10       Impact factor: 4.164

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Hypertension management in outpatient visits by diabetic patients.

Authors:  Rajender R Aparasu; Anuradha Aparasu
Journal:  Res Social Adm Pharm       Date:  2008-08-08
View more
  97 in total

1.  Trends in cardiovascular risk factor levels in the Minnesota Heart Survey (1980-2002) as compared with the National Health and Nutrition Examination Survey (1976-2002): A partial explanation for Minnesota's low cardiovascular disease mortality?

Authors:  Huifen Wang; Lyn M Steffen; David R Jacobs; Xia Zhou; Henry Blackburn; Alan K Berger; Kristian B Filion; Russell V Luepker
Journal:  Am J Epidemiol       Date:  2011-01-27       Impact factor: 4.897

2.  The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus.

Authors:  Jaime A Davidson
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

3.  Monitoring performance for blood pressure management among patients with diabetes mellitus: too much of a good thing?

Authors:  Eve A Kerr; Michelle A Lucatorto; Rob Holleman; Mary M Hogan; Mandi L Klamerus; Timothy P Hofer
Journal:  Arch Intern Med       Date:  2012-06-25

Review 4.  The Framingham Heart Study--67 years of discovery in metabolic disease.

Authors:  Michelle T Long; Caroline S Fox
Journal:  Nat Rev Endocrinol       Date:  2016-01-18       Impact factor: 43.330

5.  Trends in cardiovascular care and event rates among First Nations and other people with diabetes in Ontario, Canada, 1996-2015.

Authors:  Anna Chu; Lu Han; Idan Roifman; Douglas S Lee; Michael E Green; Kristen Jacklin; Jennifer Walker; Roseanne Sutherland; Shahriar Khan; Eliot Frymire; Jack V Tu; Baiju R Shah
Journal:  CMAJ       Date:  2019-11-25       Impact factor: 8.262

Review 6.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Authors:  Lora E Burke; Jun Ma; Kristen M J Azar; Gary G Bennett; Eric D Peterson; Yaguang Zheng; William Riley; Janna Stephens; Svati H Shah; Brian Suffoletto; Tanya N Turan; Bonnie Spring; Julia Steinberger; Charlene C Quinn
Journal:  Circulation       Date:  2015-08-13       Impact factor: 29.690

7.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 8.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

9.  Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.

Authors:  Bernhard M Kaess; Philimon Gona; Martin G Larson; Susan Cheng; Jayashree Aragam; Satish Kenchaiah; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Heart       Date:  2013-09-16       Impact factor: 5.994

Review 10.  The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.

Authors:  Ira Tabas; Alan Tall; Domenico Accili
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.